Your browser doesn't support javascript.
loading
Benchmarking computational methods for B-cell receptor reconstruction from single-cell RNA-seq data.
Andreani, Tommaso; Slot, Linda M; Gabillard, Samuel; Strübing, Carsten; Reimertz, Claus; Yaligara, Veeranagouda; Bakker, Aleida M; Olfati-Saber, Reza; Toes, René E M; Scherer, Hans U; Augé, Franck; Simaite, Deimante.
Afiliación
  • Andreani T; AI & Deep Analytics-Omics Data Science, Sanofi, Frankfurt am Main 65926, Germany.
  • Slot LM; Department of Rheumatology, Leiden University Medical Center, 2333 RC Leiden, The Netherlands.
  • Gabillard S; Life & Soft, Le Plessis-Robinson, Paris 92260, France.
  • Strübing C; Immunology & Inflammation Research, Sanofi, Frankfurt am Main 65926, Germany.
  • Reimertz C; Immunology & Inflammation Research, Sanofi, Frankfurt am Main 65926, Germany.
  • Yaligara V; Molecular Biology & Genomics, Translational Science Unit, Sanofi, Chilly-Mazarin 91385, France.
  • Bakker AM; Department of Rheumatology, Leiden University Medical Center, 2333 RC Leiden, The Netherlands.
  • Olfati-Saber R; AI & Deep Analytics, Sanofi, Cambridge, MA 02142, USA.
  • Toes REM; Department of Rheumatology, Leiden University Medical Center, 2333 RC Leiden, The Netherlands.
  • Scherer HU; Department of Rheumatology, Leiden University Medical Center, 2333 RC Leiden, The Netherlands.
  • Augé F; AI & Deep Analytics-Omics Data Science, Sanofi, Paris 91385, France.
  • Simaite D; AI & Deep Analytics-Omics Data Science, Sanofi, Frankfurt am Main 65926, Germany.
NAR Genom Bioinform ; 4(3): lqac049, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35855325
Multiple methods have recently been developed to reconstruct full-length B-cell receptors (BCRs) from single-cell RNA sequencing (scRNA-seq) data. This need emerged from the expansion of scRNA-seq techniques, the increasing interest in antibody-based drug development and the importance of BCR repertoire changes in cancer and autoimmune disease progression. However, a comprehensive assessment of performance-influencing factors such as the sequencing depth, read length or number of somatic hypermutations (SHMs) as well as guidance regarding the choice of methodology is still lacking. In this work, we evaluated the ability of six available methods to reconstruct full-length BCRs using one simulated and three experimental SMART-seq datasets. In addition, we validated that the BCRs assembled in silico recognize their intended targets when expressed as monoclonal antibodies. We observed that methods such as BALDR, BASIC and BRACER showed the best overall performance across the tested datasets and conditions, whereas only BASIC demonstrated acceptable results on very short read libraries. Furthermore, the de novo assembly-based methods BRACER and BALDR were the most accurate in reconstructing BCRs harboring different degrees of SHMs in the variable domain, while TRUST4, MiXCR and BASIC were the fastest. Finally, we propose guidelines to select the best method based on the given data characteristics.

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: NAR Genom Bioinform Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: NAR Genom Bioinform Año: 2022 Tipo del documento: Article País de afiliación: Alemania